Syndax Pharmaceuticals
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell SNDX and other ETFs, options, and stocks.About SNDX
Syndax Pharmaceuticals, Inc. engages in the development of cancer therapies. Its products include SyndAccess, Revuforj, Niktimvo, and IncyteCARES.
CEOMichael A. Metzger
CEOMichael A. Metzger
Employees270
Employees270
HeadquartersNew York, New York
HeadquartersNew York, New York
Founded2005
Founded2005
Employees270
Employees270
SNDX Key Statistics
Market cap1.41B
Market cap1.41B
Price-Earnings ratio-4.03
Price-Earnings ratio-4.03
Dividend yield—
Dividend yield—
Average volume2.03M
Average volume2.03M
High today$16.47
High today$16.47
Low today$15.59
Low today$15.59
Open price$15.77
Open price$15.77
Volume1.77M
Volume1.77M
52 Week high$22.50
52 Week high$22.50
52 Week low$8.58
52 Week low$8.58
SNDX News
TipRanks 2d
Optimistic Buy Rating for Syndax Pharmaceuticals Driven by Promising Market Position and Growth PotentialSyndax Pharmaceuticals (SNDX) has received a new Buy rating, initiated by Stifel Nicolaus analyst, Stephen Willey. Elevate Your Investing Strategy: Take advanta...
Analyst ratings
100%
of 13 ratingsBuy
100%
Hold
0%
Sell
0%
People also own
Based on the portfolios of people who own SNDX. This list is generated using Robinhood data, and it’s not a recommendation.